Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY

Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY

Objective To ascertain patient eligibility status and describe coverage of antiviral drugs and neutralising monoclonal antibodies (nMAB) as treatment for covid-19 in community settings in England.Design Retrospective, descriptive cohort study, approved by NHS England.Setting Routine clinical data fr...

Full description

Saved in:
Bibliographic Details
Main Authors: Ben Goldacre, David Evans, Sam Harper, Orla Macdonald, Alex J Walker, Richard Croker, William J Hulme, Colm D Andrews, Laurie A Tomlinson, Krishnan Bhaskaran, Henry Drysdale, Nicholas J DeVito, Ian J Douglas, Caroline E Morton, Jessica Morley, Bang Zheng, Brian MacKenna, Stephen J W Evans, Christopher T Rentsch, Helen J Curtis, Amir Mehrkar, Peter Inglesby, Jonathan Cockburn, John Parry, Frank Hester, Rose Higgins, Simon Davy, John Tazare, Viyaasan Mahalingasivam, George Hickman, Tom Ward, Rebecca M Smith, Amelia C A Green, Louis Fisher, Sebastian C J Bacon, Robin Y Park, Jon Massey, Iain Dillingham, Linda Nab, Christopher Bates, Lisa E M Hopcroft, Milan Wiedemann
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:BMJ Medicine
Online Access:https://bmjmedicine.bmj.com/content/2/1/e000276.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjmedicine.bmj.com/content/2/1/e000276.full

Similar Items